Navigation Links
Aricept Cleared for Advanced Alzheimer's Treatment

Aricept becomes the first drug to be cleared for treatment of all stages of Alzheimer's, the FDA declared on Oct 13. It had been previously approved// for treating the initial stages of the disease. Eisai shares rose on the announcement upto 6,180 yen on the Tokyo Stock Exchange on Monday morning.

Alzheimer's is a progressive disease with no known cure, which affects brain functions of memory and thinking, leading to the patient's death after much mental deterioration. Doctors are already prescribing Aricept for the advanced stages, so the approval only gives an official status to the drug use.

The other drug being used in the US for treating the advanced stages of the disease is Namenda (Forest Laboratories).

Pfizer and Eisai entered an agreement in 1994 for promoting Aricept, which was discovered and developed by Eisai. This approval is likely to see consolidation of Pfizer's share of the Alzheimer's market. Sales of the drug have been forecast at $1.9 billion through March 2007

'"/>




Page: 1

Related medicine news :

1. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
2. ‘Aricept’ drug gives an Alzheimer’s patient reason to smle
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. The Decks Cleared For HRT - Safe for Menopause Symptoms
5. Doctor Cleared Of Charges of Killing a baby
6. Orissa Villagers Jubilant as Girl Cleared Class X Examination
7. Patent for Seminal RNAi innovation Cleared in Australia
8. Risperdal Cleared By FDA To Treat Autistic Children
9. A Woman Dies Due to Breast Cancer After Being Cleared in the Breast Scan
10. Drug For Iron Overload Cleared
11. Advanced STD programs required
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Bill Howe Plumbing, Heating ... the American Heart Association; “Howe” Healthy is Your Heart Drawing Contest The ... active. Each year, Bill Howe Plumbing, Heating & Air receives over 600 entries. The ...
(Date:1/19/2017)... Marriottsville, MD (PRWEB) , ... January 19, 2017 , ... ... launched six new clients into the US market. , Over the past 20 years ... the past 4 weeks SFI has launched six new clients into the US market. ...
(Date:1/19/2017)... Georgia (PRWEB) , ... January 19, 2017 , ... ... Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons ... advancements in breast surgery. Covering topics from cosmetic breast augmentation to ...
(Date:1/18/2017)... ... 2017 , ... A recent video posting of a new fidget product gathered ... fidgeting to relieve stress and anxiety. No one was more surprised than Think ... just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive ... go untreated. , Certain Dri created this infographic to explain the seven types ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017   Science ... is excited to announce that the first five ... Biology  (RP:CB) have been published in eLife today. ... project represents the first practical evaluation of reproducibility ... in reproducible studies. Unlike other assessments of reproducibility, ...
(Date:1/19/2017)... -- New Review of Safinamide - ... and Motor Complications in Mid- to Late-stage Parkinson,s ... ... C Warren Olanow , ... 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published recently ...
Breaking Medicine Technology: